BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2022
View Archived Issues
JY-201 ADC shows promise for tumors with low HER2 expression
Read More
Tarus Therapeutics targets adenosine A2A/A2B receptors with compounds TT-10 and TT-4
Read More
ABL-103 demonstrates potent in vitro and vivo antitumor activity
Read More
ASN-90, a novel OGA inhibitor with activity in models of tauopathies and alpha-synucleinopathies
Read More
CSPC Zhongqi Pharmaceutical Technology patents new ATM inhibitors
Read More
Chinese investigators disclose new compounds for COPD
Read More
Charles University in Prague synthesizes new TET1 inhibitors
Read More
Wigen Biomedicine Technology presents new GTPase KRAS inhibitors
Read More
Medshine Discovery synthesizes PRMT5 inhibitors
Read More
U.S. DoD supports Aclipse's development of M-102 for ALS
Read More
TATX-03 antibody cocktail shows in vitro neutralizing activity toward SARS-CoV-2 Omicron BA.2
Read More
Silo Pharma produces SPU-21 liposomes for preclinical study for rheumatoid arthritis
Read More
Dual adenosine receptor A2A/A2B antagonist M-1069 reduces tumor growth in vivo
Read More
KLS-13019 prevents the development of chemotherapy-induced peripheral neuropathy in rodents
Read More
Astrocyte-produced enzyme affects neuronal activity, stroke outcomes
Read More